The Food and Drug Administration (FDA) approved Bactrim DS for the treatment of chronic bronchitis, emphysema, and chronic prostatitis in patients with HIV infection.1
Bactrim DS is a prescription medication. It works by interfering with the production of the bacterial cell walls, which are essential for the growth and reproduction of the microorganisms in the body. This prevents the cells from dividing and the bacteria from multiplying. When taken orally, Bactrim DS is absorbed into the bloodstream, with no harmful effects. It has been used for more than two decades.2
The FDA approved this medication for the treatment of bronchitis in patients with HIV infection.2 The medication is effective in reducing the severity of the disease and provides relief from symptoms such as shortness of breath and coughing.3
Bactrim DS has also been approved to treat moderate to severe emphysema in patients with HIV infection.4
The FDA approved this medication for the treatment of chronic bronchitis and chronic prostatitis in patients with HIV infection.5
Bactrim DS has also been approved to reduce the incidence of asthma and allergic diseases in adults and children.6
Bactrim DS is a prescription medication used for the treatment of bacterial infections in adults.6
Bactrim DS has been approved to treat the conditions of patients with bacterial vaginosis.7
Bactrim DS is used to treat the conditions of patients with urinary tract infections, including bacterial vaginosis, cystitis, and prostatitis.8
Bactrim DS has also been approved to treat severe bacterial vaginosis in adults.9
Bactrim DS has been approved to treat the following conditions in patients with severe bacterial vaginosis, as well as urinary tract infections, in adults:10
Bactrim DS has been approved to treat patients with severe bacterial vaginosis in adults.10
It works by interfering with the production of the cell walls of bacteria, which are essential for the growth and reproduction of the microorganisms in the body. Bactrim DS has been shown to improve the symptoms of certain bacterial infections and treat the following conditions:11
1
Bactrim DS has been shown to be effective in treating patients with mild to moderate bacterial vaginosis.12
Bactrim DS has been shown to be effective in treating certain infections, including the following:
It works by inhibiting the production of the cell walls of bacteria, which are essential for the growth and reproduction of the microorganisms in the body.
Mesansman et al. (2004) showed that bactrim in combination with rifampicin significantly reduced the incidence of acute bacterial sinusitis in a population of Thai patients. The authors concluded that bactrim could be a potential treatment for sinusitis. In a study by Gao et al., they reported that bactrim could be effective against bacterial infections in an in vitro infection model. However, the authors recommended that it is recommended that bactrim be used with caution, especially in patients with underlying health conditions or who are receiving prolonged antibiotic treatment. Bactrim, however, may be less effective against viral infections.
The present study aimed to evaluate the efficacy and safety of bactrim in combination with rifampicin for the treatment of acute bacterial sinusitis in Thai patients.
Forty Thai patients with acute bacterial sinusitis complicated with bacterial sinus syndrome were randomized to receive either a single daily dose of 2 g rifampicin or 400 mg of rifampicin as a single dose of 2 g or an 8-week single-dose regimen of rifampicin for two weeks. In addition, a second dose of rifampicin was added to the second dose of bactrim. The clinical and demographic characteristics of the patients, including age, sex, weight, body mass index (BMI), and concomitant antibiotic treatment history, were recorded at the first visit. Bacterial infection was defined by the presence of pus in both the lower and upper airways (see Table ).
The mean patient age was 64.4 years, with a range of 34.2 to 73 years. In the multivariate analysis, age was the independent independent predictive factor for acute bacterial sinusitis (odds ratio [OR] 2.7; 95% confidence interval [CI], 1.3 to 5.4). The multivariate analysis showed that the presence of a history of hypersensitivity to sulfa drugs, known as hypersensitivity to penicillins, was an independent predictor of bacterial sinusitis (OR 1.4; 95% CI, 1.1 to 1.9).
The patients were hospitalized at our outpatient clinic for a minimum of six days with the diagnosis of bacterial sinusitis (see Table ).
In addition, the patients were followed up by a primary care physician, and the patients were monitored in the outpatient department for the first year and for a further two years.
The patients who were hospitalized with a diagnosis of bacterial sinusitis and who had received antibiotic treatment for bacterial sinusitis were followed for the first year of follow-up and the patients were followed for the second year of follow-up.
In addition, the patients were followed for a further 2 years for bacterial infection.
The efficacy of bactrim was evaluated by the treatment regimen as follows:
Safety and adverse events of bactrim were evaluated using the QT interval in the ECG in the treatment period and the occurrence of any adverse events.
Safety data were obtained from patients who received bactrim for one year. A detailed description of these safety data is in Table.
The adverse events reported were:
Bactrim is a combination of two antibiotics called sulfamethoxazole and trimethoprim. The drug is sold as the brand-name product, Bactrim DS, and is used for the treatment of bacterial infections in the treatment of urinary tract infections, pneumonia, sinusitis, bronchitis, and more. Bactrim is available as a generic drug called Bactrim DS-S (sulfamethoxazole/trimethoprim), and the active ingredient of Bactrim is sulfamethoxazole-trimethoprim. Bactrim is a combination antibiotic. It is used for the treatment of infections of the urinary tract, respiratory tract, skin, and soft tissue caused by susceptible bacteria.
The drug works by inhibiting the production of the bacterial enzyme that makes the active substance trimethoprim. This enzyme makes the drug more effective against the bacteria that cause the infection. The Bactrim DS drug works to kill the bacteria that cause the infection by producing bacterial growth on the surface of the body. This kills the bacteria that cause the infection.
Bactrim DS is also available as a generic drug called Bactrim DS. It is used for the treatment of bacterial infections in the treatment of urinary tract infections, pneumonia, sinusitis, bronchitis, and more. Bactrim DS is available as a generic drug and is used for the treatment of a wide variety of bacterial infections. Bactrim DS is a combination antibiotic. It is sold as the brand-name product, Bactrim DS, and is used for the treatment of bacterial infections in the treatment of urinary tract infections, pneumonia, sinusitis, bronchitis, and more. Bactrim DS is also used for the treatment of sexually transmitted infections and is also available as a generic drug.
Take Bactrim DS as prescribed. You can take Bactrim DS tablets, capsules, and oral suspension as instructed by your doctor. Swallow the tablet whole with a full glass of water. Take Bactrim DS at the same time each day. Do not miss any doses. Do not stop taking Bactrim DS without talking to your doctor, and if you miss a dose, continue taking the tablet at the same time each day.
Follow the instructions on your prescription label. The dose of Bactrim DS is usually prescribed to be taken once every day at the same time. Take the tablet as directed and the dose should be evenly distributed.
Bactrim is a prescription antibiotic medicine used for the treatment of infections of the urinary tract. Bactrim is also used to treat bacterial respiratory infections, including pneumonia, bronchitis, and sinusitis. Bactrim is available in various forms, including oral tablets, suspension, and chewable tablets.
Bactrim is manufactured by the company Takeda. Takeda is the brand name of the generic Bactrim manufactured by Sandoz. Takeda is the brand name of the brand Bactrim. Bactrim is available as a generic drug.
The active ingredient in Bactrim is sulfamethoxazole-trimethoprim. Sulfamethoxazole and trimethoprim are the principal ingredients in Bactrim. These ingredients are used to prevent the growth of bacteria and to treat various infections of the urinary tract. The tablets are available in an strengths of 500 mg and 1,000 mg. Sulfamethoxazole and trimethoprim are also available in strengths of 125 mg and 250 mg. Each tablet contains sulfamethoxazole 200 mg and trimethoprim 1 mg.
The most common adverse effects associated with Bactrim use include:
The serious adverse effects of Bactrim use include:
The serious adverse effects of Bactrim include:
The recommended dosage of Bactrim is 500 mg twice a day and 1,000 mg three times a day.
Medically reviewed by Jessica Swirble, PharmDLast updated on March 26, 2025
Drug Information| | |
Sulfamethoxazole and trimethoprim are tetracyclines that act primarily by inhibiting the growth of microorganisms. They are commonly used in the treatment of bacterial vaginosis, trichomoniasis, gonorrhea, and certain sexually transmitted infections (STIs). Bactrim is an alternative to the commonly used combination antibiotics used for treating urinary tract infections, including sulfamethoxazole and trimethoprim.
Treatment of infections caused by susceptible anaerobic bacteria involves both aerobic and anaerobic infections. Tetracycline antibiotics are typically reserved for conditions that do not require bacterial cell walls.
Bactrim is primarily used to treat infections caused by anaerobic bacteria and non-aerobic infections. Tetracycline antibiotics are often used to treat conditions such as acute bacterial vaginosis, dysuria, and chlamydia. Bactrim is sometimes used for the treatment of STIs such as gonorrhea and certain sexually transmitted infections (STIs).
The chemical structure of Sulfamethoxazole & Trimethoxazole is similar to that of trimethoprim, with a diuretic effect. Sulfamethoxazole & trimethoprim have a similar affinity for and anaerobic bacteria, with a greater affinity for and a greater selectivity for a wide range of anaerobic bacteria.
Tetracycline antibiotics bind to bacterial cell walls, inhibiting protein synthesis. This selectivity allows for extended bacterial growth and increased bacterial resistance to bacterial infection. Tetracycline antibiotics also penetrate tissues such as the vagina and lungs, where they inhibit the growth of bacteremia, a serious infectious illness caused by anaerobic bacteria.
The effectiveness of Bactrim and Trimethoxazole for treating infections in both hospital and academic settings isdocumented in numerous clinical trials. The trials included over 300 patients with infections caused by susceptible anaerobic bacteria. The overall goal was to improve patient outcomes when treatment is given in the academic setting.
The choice of antibacterial agent depends on the type, severity, and specific characteristics of the infection. Bactrim and Trimethoxazole are often used together in combination therapy, to treat a wide range of anaerobic bacteria. The combined use of Bactrim and Trimethoxazole may result in increased bacterial resistance to the antibiotics, which can lead to serious adverse outcomes.
Antibiotics are commonly used to treat infections caused by susceptible anaerobic bacteria. Bactrim and Trimethoxazole are often used together in combination therapy to treat a wide range of anaerobic bacteria.
Stade de France Pharmacy